Project Grant HT94252510655
Award Date
7/15/25
Completion Date
7/14/27
Dollars Obligated
$320K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Portland, OR 97239, USA
Similar Awards
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $999,823 Project Grant to Oregon Health & Science University (OHSU) on June 1, 2024. The grant, titled "TARGETING NEURODEGENERATION IN THE AGED DEMYELINATED CNS," supports OHSU's biomedical research efforts to investigate innovative treatments for neurological disorders. Through this funding, OHSU will conduct basic, applied, and advanced research to develop new medical...
The federal Project Grant award, with ID HT94252510748, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award, totaling $2,358,273.00, will support research at Oregon Health & Science University (OHSU) from September 1, 2025, through August 31, 2029. The research aims to investigate postural motor activation deficits following mild traumatic brain injury (mTBI), with the goal of translating laboratory findings into...
The Defense Health Agency awarded a $472,251.00 Project Grant to Oregon Health & Science University (OHSU) under the Military Medical Research and Development program (CFDA 12.420) to identify novel compounds for the treatment of pPDAchordoma and other SMARCB1-deficient rare tumors. The award period is from August 1, 2023 to July 31, 2026. Through this grant, OHSU will conduct research and development activities to discover and evaluate new drug compounds that could potentially treat these...
The federal Project Grant award of $391,743.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Oregon Health & Science University (OHSU). The award is for the development of a "compact, high resolution, 3D optical imager for anterior eye injury and disease." This research aims to advance innovative medical imaging technologies that can transform healthcare for military service members, veterans, and the...
This Project Grant award of $1,401,794.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Oregon Health & Science University (OHSU). The funding will support a 3-year research project investigating the impact of recent childbirth on breast cancer prognosis and tumor molecular phenotypes among young Black and White women. The research aims to enhance understanding of breast cancer disease progression and outcomes in this...
This federal Project Grant award of $1,525,292 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a research project led by Oregon Health & Science University (OHSU) to characterize the progression of prostate cancer through integrated analysis of single-cell data. The project, which commenced on September 30, 2024 and is scheduled for completion by September 29, 2027, aims to advance the understanding of prostate cancer biology and...
Oregon Health & Science University was awarded a $494,340 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 2022 through July 2025 to elucidate mechanisms of rapid metastatic recurrence in pancreatic ductal adenocarcinoma. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
This Project Grant award of $395,134.00, provided by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), will fund a collaborative pilot project between Oregon Health & Science University (OHSU) and the Warm Springs Tribe to address health disparities in the Native American population. The project aims to transform healthcare for military service members and the broader public through innovative biomedical research focused...
The U.S. Defense Health Agency has awarded a $623,953 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to Oregon Health & Science University (OHSU) to conduct research on "Improved and Safer Chemotherapy of Medulloblastoma Using a Self-Assembled Nanomaterial." The award period runs from September 1, 2025, through August 31, 2027. This research project aims to develop innovative nanomaterial-based approaches to enhance the safety and efficacy...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $618,866.00 to Oregon Health & Science University (OHSU) to address health disparities in the Native American population through a pilot collaboration with the Warm Springs Tribe. The award is effective from September 29, 2024 through September 28, 2027. OHSU, a prominent academic medical center and research university, will...